Drug Pipeline

Olanzapine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
18
Active Studies
14
Recruiting
8
Phase 3
10
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-20 NCT07403370
Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis
Trial completed
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-08 NCT07633236 Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients… Phase 3 Recruiting
Active Studies by Phase
Phase 4
2
Phase 3
8
Phase 2
4
Phase 1/2
1
Phase 1
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT04478838 "Extended" (Alternate Day) Antipsychotic Dosing Schizophrenia and Related Disorders Recruiting
NCT07482891 An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron… Chemotherapy-induced Nausea and Vomiting Recruiting
Phase 3
NCT05669742 Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in… Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics Recruiting
NCT07413809 Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs… Multiple Myeloma Recruiting
NCT07208305 Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting Nausea Recruiting
NCT07565428 Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative… Negative Symptoms of Schizophrenia Recruiting
NCT06200181 Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for… Misuse, Opioid Recruiting
NCT05303064 Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects… Schizophrenia Recruiting
NCT07633236 Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients… Oncology Patients Receiving Chemotherapy Recruiting
NCT04939090 Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced… Advanced Malignant Solid Neoplasm Active, Not Recruiting
Phase 2
NCT05705492 Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With… Advanced Malignant Solid Neoplasm Recruiting
NCT06995508 Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing… Cancer-Associated Anorexia Recruiting
NCT06554613 Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC Non-Small Cell Lung Cancer Recruiting
NCT07581405 GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for… Gastric Adenocarcinoma Not Yet Recruiting
Phase 1/2
NCT05814640 Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) Depression Recruiting
Phase 1
NCT03741478 Intranasal Insulin and Olanzapine Study in Healthy Volunteers Healthy Controls Active, Not Recruiting
Not specified
NCT06251635 Effects of Antipsychotics on Brain Insulin Action in Females Insulin Resistance Recruiting
NCT07442890 A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent… Lung Cancer Not Yet Recruiting
Sponsors Running Olanzapine Trials
Disease Areas
Get alerts when Olanzapine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free